NASDAQ:ACRX - AcelRx Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$2.94 -0.21 (-6.67 %)
(As of 12/13/2018 04:48 AM ET)
Previous Close$3.15
Today's Range$2.9150 - $3.18
52-Week Range$1.65 - $5.05
Volume3.68 million shs
Average Volume1.49 million shs
Market Capitalization$208.01 million
P/E Ratio-2.67
Dividend YieldN/A
Beta1.83

Analyst Ratings

AcelRx Pharmaceuticals (NASDAQ:ACRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for AcelRx Pharmaceuticals in the last 12 months. Their average twelve-month price target is $8.6667, suggesting that the stock has a possible upside of 194.78%. The high price target for ACRX is $10.00 and the low price target for ACRX is $7.00. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.862.862.632.63
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $8.6667$8.6667$5.50$5.50
Price Target Upside: 194.78% upside102.97% upside86.44% upside34.15% upside

AcelRx Pharmaceuticals (NASDAQ:ACRX) Consensus Price Target History

Price Target History for AcelRx Pharmaceuticals (NASDAQ:ACRX)

AcelRx Pharmaceuticals (NASDAQ:ACRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/12/2018HC WainwrightReiterated RatingBuy$9.00HighView Rating Details
12/11/2018OppenheimerReiterated RatingHoldHighView Rating Details
12/11/2018Cantor FitzgeraldReiterated RatingBuy$9.00HighView Rating Details
11/2/2018LADENBURG THALM/SH SHSet Price TargetBuy$10.00HighView Rating Details
10/23/2018B. RileyInitiated CoverageBuy ➝ Buy$9.00HighView Rating Details
10/22/2018Royal Bank of CanadaSet Price TargetBuy$7.00MediumView Rating Details
10/15/2018Jefferies Financial GroupUpgradeHold ➝ Buy$8.00HighView Rating Details
10/13/2017Piper Jaffray CompaniesReiterated RatingHold$2.00N/AView Rating Details
10/12/2017Roth CapitalSet Price TargetBuy$8.00N/AView Rating Details
8/9/2017Stifel NicolausUpgradeHold ➝ BuyHighView Rating Details
8/1/2017CowenReiterated RatingHoldHighView Rating Details
(Data available from 12/13/2016 forward)
This page was last updated on 12/13/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel